Weekly-dose doxorubicin (WDA) in advanced breast cancer
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 7 (2) , 133-139
- https://doi.org/10.1016/s0167-8140(86)80092-5
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Early and delayed clinical cardiotoxicity of doxorubicinCancer, 1985
- Pharmacokinetic study of IV infusions of adriamycinEuropean Journal of Clinical Pharmacology, 1985
- An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patientsCancer, 1980
- Dependence of the cytostatic effect of adriamycin on drug concentration and exposure time in vitroBritish Journal of Cancer, 1980
- Cancer of the BreastNew England Journal of Medicine, 1980
- Dose response evaluation of adriamycin in human neoplasiaCancer, 1977
- Adriamycin cardiotoxicityThe American Journal of Surgical Pathology, 1977
- Superiority of adriamycin over oral nitrosoureas in patients with advanced breast carcinoma.A southwest cancer chemotherapy study group studyCancer, 1974
- AdriamycinAnnals of Internal Medicine, 1974
- Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high-dosage scheduleCancer, 1974